Analyst Sentiment Shifts as Palantir Shares Find Favor Post-Correction

UBS and Citi upgrade Palantir to 'Buy' after a 35% pullback, citing strong AI-driven growth following robust Q4 results and a 70% revenue surge.

Following a recent pullback, Palantir Technologies Inc. is attracting renewed positive attention from Wall Street research firms. In a notable shift, two major institutions upgraded their ratings to "Buy" on Friday. This change in perspective raises questions about its timing, emerging as it does after a significant price decline.

Strong Quarterly Performance Provides Foundation

The analyst upgrades did not occur in a vacuum. On February 2, Palantir reported robust fourth-quarter 2025 results that exceeded market expectations. Revenue reached $1.41 billion, a 70% year-over-year increase and surpassing estimates of $1.34 billion. Earnings per share came in at $0.25, also beating the anticipated $0.23.

A standout performer was the U.S. commercial business, which expanded by 137% and served as a primary growth engine. The company also reported a "Rule of 40" score of 127%, a metric that combines growth and profitability. For the full year 2026, management provided revenue guidance of approximately $7.19 billion, implying 61% growth.

Dual Upgrades Follow Market Retreat

The specific catalyst for the renewed optimism was action from UBS and Citi, both raising their ratings on February 27. This move came after the equity corrected roughly 35%, having retreated from a previous trading range. From the analysts' viewpoint, the decline represents a reassessment following a strong rally rather than a fundamental alarm.

This is reflected in the broader consensus, which stands at "Moderate Buy" with an average price target of $191.05. On a technical basis, the Relative Strength Index (RSI) was recently noted at 39.69, nearing oversold territory.

Growth Thesis Endures Despite Valuation Concerns

The rationale behind the upgrades centers on sustained growth prospects. UBS analyst Karl Keirstead cited expected demand for AI and data infrastructure, forecasting 70% revenue growth by 2026 alongside stable margins in the mid-50% range. UBS maintains a $180 price target, based on a 50x multiple of estimated 2027 free cash flow.

Citi sees additional potential on the revenue front, suggesting an "Upside Scenario" of 80% growth by late 2026. Other price targets in the market include Mizuho's $195 and Rosenblatt's $150.

According to provided data, the stock last traded at €114.14, reflecting a 13.40% decline over the preceding 30 days.

Institutional and Insider Activity Presents a Mixed Picture

Trading activity among major investors shows divergent signals. In the third quarter, US Bancorp DE increased its position by 8.3%, and Chase Investment Counsel was also a buyer. Subsequent filings showed Vanguard and State Street making modest additions to their holdings.

Conversely, Andra AP fonden reduced its stake by 22.8%, selling 77,600 shares. Overall, institutional ownership is reported at 45.65%.

On the insider front, selling has been more prevalent. On February 20, manager Ryan Taylor disposed of 19,988 shares at an average price of $133.72, generating proceeds of $2.67 million and reducing his holding by 8.35%. Over the past quarter, insider sales totaled over one million shares worth approximately $142.2 million.

In summary, the recent analyst pivot bets that Palantir's powerful growth—particularly in U.S. commercial operations—will justify its valuation. The critical test will be whether the company can deliver on its projected $7.19 billion revenue for 2026 while maintaining stable margins.